Active Filter(s):
Details:
Under the agreement, Symrise is guaranteed to purchase minimum annual volumes of Ceapro’s high value active ingredients. These skills merge in the fields of active ingredients, biopharmaceuticals and drug-delivery solutions.
Lead Product(s): Oat Beta Glucan,Avenanthramides
Therapeutic Area: Dermatology Product Name: Juvente
Highest Development Status: Approved Product Type: Small molecule
Recipient: Ceapro
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement March 10, 2022